Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: LODESTONE BIOMEDICAL INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-19 to 2024-09-18
Current total value of award: $2050000
Description: TOPIC 405: INTRATUMORAL BIOSENSING FOR IN VIVO PHARMACOTYPING